OPEN PROCEDURE FOR THE AWARDING TO A CONTRACT RESEARCH ORGANIZATION (CRO) OF SERVICES FOR THE MANAGEMENT OF THE RANDOMIZED MULTICENTER CLINICAL STUDY: "COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL", THROUGH THE SINTEL PLATFORM AI
TEDAS your procurement assistant
Ask a question about this procurement
No documents